-
1
-
2
-
3
-
4
-
5
-
6
458 Concomitant tamsulosin and silodosin treatment is not associated with a better clinical outcome or an increased stone free rate in patients treated with ESWL: A randomized-plac...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
7
-
8
Overall adverse events in patients treated with abiraterone and enzalutamide for metastatic castration resistant prostate cancer: Meta-analysis of randomized clinical trials and re...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
9
SC176 - Age influence on adverse events in patients treated with abiraterone plus prednisone, enzalutamide and radium223 for metastatic castration resistant prostate cancer: Analys...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
10
SC175 - Overall adverse events in patients treated with abiraterone and enzalutamide for metastatic castration resistant prostate cancer: Meta-analysis of randomized clinical trial...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
11
Age influence on adverse events in patients treated with abiraterone plus prednisone, enzalutamide and radium223 for metastatic castration resistant prostate cancer: Analysis of re...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
12
-
13
-
14
-
15
896 - Overall adverse events in patients treated with radium223 for metastatic castration resistant prostate cancer: Registry study and analysis of real life data from EudraVigilan...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
16
903 - Age influence on adverse events in patients treated with abiraterone plus prednisone, enzalutamide and radium-223 for metastatic castration resistant prostate cancer: Analysi...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
17
Age influence on adverse events in patients treated with abiraterone plus prednisone, enzalutamide and radium-223 for metastatic castration resistant prostate cancer: Analysis of r...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
18
-
19
-
20
Vaccination apps: a missing opportunity from various perspectives?
Veröffentlicht in European journal of public health
VolltextArtikel